If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.
Researchers have identified new details about the link between certain cancer therapies and heart complications. Could their work lead to key improvements in patient care?
Professional consensus supports the use of ultrasound for initial imaging evaluation of patients presenting in the ED with suspected urinary stone disease (USD). However, as of 2018, only 2% of these patients received ultrasound while some 59% had CT.
The new-look adjustable stents, not yet fully approved by the FDA, can be expanded as a child ages. The hope is that these stents will never need to be replaced.
Sean Fain, PhD, vice chair of radiology and research and a professor of radiology, University of Iowa, discusses how long-COVID lung damage can be tracked using xenon (Xe) gas MRI and quantitative CT at RSNA 2022.
The American College of Cardiology, American Heart Association, European Society of Cardiology and World Heart Federation all collaborated on a joint statement aimed at updating the rules and regulations associated with randomized clinical trials
